Plain-English translation of NCT06922175 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study that looks back at medical records of patients who have taken cenobamate, a medication for focal-onset seizures that haven't responded well to other treatments. Researchers want to understand how this medication affects patients' healthcare use — like hospital visits, emergency room trips, and doctor appointments — before and after starting the treatment. The goal is to learn whether this medication helps reduce the burden on the healthcare system while managing seizures.
Many people with focal-onset epilepsy continue having seizures even after trying multiple anti-seizure medications. This medication is a newer option, but doctors and patients need real-world evidence about whether it actually helps reduce emergency visits and hospitalizations — not just whether it stops seizures. This study provides that practical information.
You likely qualify if…
You likely don't qualify if…
This is not an active treatment study — researchers will simply review your existing medical records from before and after you started the medication. There are no study visits, pills to take, or new treatments to receive. Your doctors' office or hospital will provide your chart information to the research team, which will be analyzed to compare how often you needed emergency care, hospitalization, or other medical services before and after beginning this medication. The study involves data from 200 patients across 10 sites in 5 countries.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
Germany
Netherlands
Spain